GlassScriptPhysician profile
Amanda Duvall
NPI 1164043477
$858.43
in general payments reported to CMS, 2019-2025
11 companies · $90.44 in 2025
The $90.44 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $160 · 2023: $131 · 2024: $360 · 2025: $90.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $232.16 | 2023-2024 | Veozah |
| Baxter Healthcare | $171.35 | 2023-2025 | Tisseel, Floseal, Perclot |
| Janssen Pharmaceuticals, INC | $117.14 | 2021 | |
| Minerva Surgical, INC | $93.50 | 2022 | |
| Meditrina | $79.48 | 2024-2025 | |
| Intuitive Surgical, INC. | $66.33 | 2022 | |
| Organogenesis INC. | $24.35 | 2024 | |
| Coopersurgical, INC. | $21.20 | 2025 | Rumi II Koh-Efficient |
| Evofem Biosciences, INC. | $19.11 | 2024 | |
| Hologic Sales and Service, LLC | $17.84 | 2025 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Ethicon US, LLC | $15.97 | 2024 | Dermabond Prineo, Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Duvall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.